As we know the multi-stakeholder world is increasingly complex, with shifting dynamics and stakeholder groups engaging in different ways, through different channels, at different times and by different customer-facing functions. It’s essential that a multi-stakeholder approach is taken or we run the risk of falling behind.
In this whitepaper we explore the new integrated multi-stakeholder approach and reflect on the impact it’s having on the industry as a whole.
Find out more by downloading your free copy today >>>
With expert contributions from:
Hans Gilhuyus, Global Multi Channel Capabilities Director, GSK
Jane Griffiths, Global Head, Actelion
Markus Kosch, Vice President, Oncology Portfolio, Europe, Japan & Developed Asia, Pfizer Oncology
Sebastian Guth, Executive Vice President and Chief Marketing Officer, Bayer Pharmaceuticals
Barrett Madrigal, Senior Director Eli Lilly Japan KK. Operation Officer, Member of Global Bio-Medicines Lead Team
Bob Oliver, Chief Executive Officer, VClinBio
Kabir Nath, CEO, Otsuka Pharmaceuticals US
Discover how the integrated multi-channel approach will change pharma forever, download your copy today >>>
Balancing payers, patients and physicians: An integrated, multi-stakeholder approach